REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanpar Pharmachem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanpar Pharmachem Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Shanpar Pharmachem Private Limited is an enterprise in India, with the main office in Chennai. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on August 17, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 8.25% in 2024. There was a total growth of 18.39% in Shanpar Pharmachem Private Limited’s total assets over the same period. The enterprise’s net profit margin increased by 0.06% in 2024.

Legal Address
7, South Gangai Amman Koil 1St Street Choolaimedu
Chennai; Tamil Nadu; Postal Code: 600094

Contact Details: Purchase the Shanpar Pharmachem Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Shanpar Pharmachem Private Limited report to view the information.
Financial Auditors:
Purchase the Shanpar Pharmachem Private Limited report to view the information.
Incorporation Date:
August 17, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Shanpar Pharmachem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
8.25%
Total Operating Revenue
8.29%
Operating Profit
9.57%
EBITDA
8.76%
Net Profit/Loss for the Period
12.34%
Total Assets
18.39%
Total Equity
28.08%
Operating Profit Margin
0.03%
Net Profit Margin
0.06%
Return on Equity (ROE)
-3.07%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?